Sodium mycophenolate

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 56, Issue 4, 2000, Pages 432-433

  Rihs, Grety ^a   Papageorgiou, Christos ^a   Pfeffer, Sabine ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEXATION;

IMMUNOSUPPRESSIVE DRUGS; INTERMOLECULAR HYDROGEN BONDS; INTRA-MOLECULAR HYDROGEN BONDS; METHANOLIC SOLUTION; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACIDS; PHENOLIC HYDROXY GROUP; TITLE COMPOUNDS;

HYDROGEN BONDS;

MYCOPHENOLIC ACID; SODIUM;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYCOPHENOLIC ACID; SODIUM;

EID: 0346477180     PISSN: 01082701     EISSN: 16005759     Source Type: Journal    
DOI: 10.1107/S0108270100000524     Document Type: Article

References (11)

1. Behrend, M. (1998). Expert Opin. Invest. Drugs, 7, 1509-1519.
2. Enraf-Nonius (1994). CAD-4 EXPRESS. Version 5.1/1.2. Enraf-Nonius, Delft, The Netherlands.
3. Harrison, W., Shearer, H. M. M. & Trotter, J. (1972). J. Chem. Soc. Perkin Trans. 2, pp. 1542-1544.
4. Holt, C. D., Sievers, T. M., Ghobrial, R. M., Rossi, S. J., Goss, J. A. &McDiarmid, S. V. (1998). BioDrugs, 10, 373-384.
5. Johnson, C. K. (1976). ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA.
6. Keller, E. (1997). SCHAKAL97. University of Freiburg, Germany.
7. Makara, G. M., Keseru, G. M., Katjar-Peredy, M. & Anderson, W. K. (1996). J. Med. Chem. 39, 1236-1242.
8. Schmouder, R., Arns, W., Merkel, F., Schoudrhury, S., Russell, D. & Taccard, G. (1999). Transplantation, 67 (Suppl.), S203.
9. Sheldrick, G. M. (1990). Acta Cryst. A46, 467-473.
10. Sheldrick, G. M. (1993). SHELXL93. University of Göttingen, Germany.
11. Sintchak, M. D., Fleming, M. A., Futer, O., Raybuck, S. A., Chambers, S. P., Caron, P. R., Murcko, M. A. & Wilson, K. P. (1996). Cell, 85, 921-930.